Michelle Mello, professor of law and health policy, joins The Future of Medicine for a conversation about one of the most frustrating and consequential parts of American healthcare: prior authorization.
SHP faculty are among those teaching at an intensive weeklong workshop for health-care leaders to learn how to take what they know and turn it into real, measurable change.
Michele Barry, senior associate dean of global health for Stanford Medicine, shares five things about the serious Ebola outbreak in the Democratic Republic of the Congo.
A study by physician-economist Marcella Alsan examines how racial bias in pulse oximeters leads to Black patients receiving less follow-up care than white patients.
The Lancet Global Health comment by Ruth Gibson and colleagues calls for reopening the “humanitarian corridor” connecting the Gaza Strip to other Palestinian hospitals for critically ill patients—especially children—who cannot receive proper care in Gaza.
Jail-based HCV interventions, especially those offering treatment, significantly enhance HCV elimination in people who inject drugs—and are a cost-effective public health strategy.
In a new policy brief, SHP's Alyce Adams and her colleague, Mateen Ghassemi, address financial toxicity in cancer care through Medical Financial Assistance (MFA) Policy.
New research by SHP courtesy faculty member Marcella Alsan shows that beneath the country's polarization over gun violence, those who own firearms and those who don't share the common goal of safety, but disagree about the means.
In this JAMA Health Forum commentary, SHP's Michelle Mello discusses the potential pros and cons of a new pilot project in Utah, which is testing an AI agent to renew prescriptions.
SHP's Maria Polyakova and Victoria Udalova compare physician income in the United States, Canada, Sweden and the Netherlands. U.S. doctors earn significantly more than their foreign counterparts—but that's largely because Americans across the board earn more.
Private equity (PE) firms are gaining control of U.S. health care, threatening the fair opportunity for optimal health for all, writes SHP's Marcella Alsan in this NEJM Perspective.
In this video, Jeremy Goldhaber-Fiebert discusses choosing a model type to evaluate a medical decision, emphasizing the importance of considering the underlying process.
Global health-care executives are partnering with Stanford Medicine to develop an evidence-based policy agenda that will guide the Future of Health’s members over the next decade.
